DGAP-News

Abivax announces the release of its 2020 half-year financial report

DGAP-News: ABIVAX / Key word(s): Half Year Results Abivax announces the release of its 2020 half-year financial report 30.09.2020 / 18:00 The issuer is solely responsible for the content of this announcement. Abivax announces the release of its 2020 half-year financial report

PARIS, France, September 30, 2020 - 06:00 p.m. (CET) - Abivax (Euronext Paris: FR0012333284 - ABVX), a clinical-stage biotechnology company harnessing the immune system to develop novel treatments for inflammatory diseases, viral diseases and cancer, today announces the publication of its 2020 half-year financial report. This document is available in electronic version on the website of the company (www.abivax.com) and on the website of the French financial markets authority, AMF (www.amf-france.org).

About Abivax (www.abivax.com)
Abivax, a clinical stage biotechnology company, is mobilizing the body's natural immune machinery to treat patients with autoimmune diseases, viral infections, and cancer. Abivax is listed on Euronext compartment C (ISIN: FR0012333284 - Mnémo: ABVX). Based in Paris and Montpellier, Abivax has two drug candidates in clinical development, ABX464 to treat severe inflammatory diseases, and ABX196 to treat hepatocellular carcinoma.

More information on the company is available at www.abivax.com. Follow us on Twitter @ABIVAX_.

******

Contacts

Abivax Finance Department Didier Blondel [e-mail] [phone]	Investors LifeSci Advisors Chris Maggos [e-mail] [phone]	Press Relations & Investors Europe MC Services AG Anne Hennecke [e-mail] [phone]
Public Relations France Actifin Ghislaine Gasparetto [e-mail] [phone]	Public Relations France DGM Conseil Thomas Roborel de Climens [e-mail] [phone]	Public Relations USA Rooney Partners LLC Marion Janic [e-mail] [phone]

---

30.09.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

---

1137910  30.09.2020